Entering text into the input field will update the search result below

9 Meters Biopharma stock soars 19% on US patent for NM-136 to treat metabolic disorders

Apr. 13, 2022 8:06 AM ET9 Meters Biopharma, Inc. (NMTRQ) StockBy: Ravikash Bakolia, SA News Editor

Business woman signs a patent. Intellectual property protection concept. Patent attorney.

Irina Vodneva/iStock via Getty Images

  • 9 Meters Biopharma (NASDAQ:NMTR) said the U.S. Patent and Trademark Office (USPTO) has allowed patent application No. 16/781,304, which provides protection for the use of NM-136 to treat hyperphagia (excessive hunger), serious metabolic conditions such as obesity, and for reducing fatty

Recommended For You

More Trending News

About NMTRQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NMTRQ--
9 Meters Biopharma, Inc.